跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,903 条关于
“Scholar Rock Netherlands B.V.”
全部
1,903
临床试验
774
药物
171
机构
264
资讯
694
昨天
CHMP Backs 12 New Medicines, Including First Oral Daily Hidradenitis Suppurativa Option and Earlier-Line Tecvayli
去年
Scholar Rock Submits Apitegromab BLA to FDA for Spinal Muscular Atrophy Treatment
去年
Scholar Rock's Apitegromab Shows Promise in SMA, Faces Financial and Development Hurdles
6个月前
Redmile Group Invests $49 Million in Scholar Rock as Apitegromab Nears Regulatory Resubmission
去年
Scholar Rock Seeks FDA Approval for Novel SMA Add-on Therapy Apitegromab
去年
Scholar Rock's Apitegromab Shows Promise in Spinal Muscular Atrophy Treatment
9个月前
Scholar Rock Faces Manufacturing Setback as FDA Issues Warning Letter to Catalent Partner Ahead of Apitegromab Launch
去年
Scholar Rock Appoints David L. Hallal as CEO, Strengthens Leadership Team Ahead of Apitegromab Launch for SMA
去年
Apitegromab Shows Promise in Phase III Spinal Muscular Atrophy Trial, Scholar Rock Reports
去年
Scholar Rock's Apitegromab Shows Promise in Phase 3 Trial for Spinal Muscular Atrophy
第 1 页,共 70 页
上一页
下一页